The Path to Becoming a Data-Driven Company
As a manufacturer of pharmaceutical primary packaging and drug delivery systems, Gerresheimer AG has been growing dynamically for years. A historically decentralized organizational structure and a number of acquisitions have resulted in inconsistent data structures, which make it considerably more difficult to evaluate and analyze financial and production data across the group. For this reason, an initiative was launched at the company's headquarters in Düsseldorf, in collaboration with several production sites, with the aim of creating a group-wide data platform that structures, cleanses, and prepares data in a uniform manner, making it easily accessible and usable. Processes can now be designed more efficiently at the sites and across the company, problem areas can be identified, and growth potential can be tapped.
Benefits for our Customers
- Improved transparency
- Consistent key figures
- Optimized corporate management thanks to company-wide reporting capabilities and increased data quality and timeliness
About Gerresheimer
Gerresheimer is an innovative system and solution provider and global partner to the pharmaceutical, biotech, and cosmetics industries. The company offers a comprehensive portfolio of containment solutions for drugs, drug delivery systems, and medical devices, as well as solutions for the healthcare industry. Its range of services includes digital solutions for therapy support, drug pumps, syringes, pens, autoinjectors, and inhalers, as well as injection vials, ampoules, tablet containers, infusion, drip, and syrup bottles. Gerresheimer ensures that drugs reach patients safely and can be administered reliably.
With 35 production sites in 16 countries in Europe, America, and Asia, Gerresheimer has a global presence and produces locally for regional markets. With around 12,000 employees, the company generated sales of around €2 billion in 2023. Gerresheimer AG is listed on the MDAX of the Frankfurt Stock Exchange (ISIN: DE000A0LD6E6).
